Quick answer
Is mitral valve disease common in Welsh Springer Spaniels?
No, MMVD is best known in small toy breeds and is not documented as a hallmark condition for Welsh Springer Spaniels specifically, though it can still occur as a general aging-heart condition.
The valve that quietly keeps blood moving in one direction for over a decade can start leaking a little, then a little more, and this disease is entirely about managing that slow drift.
Owners of senior Welsh Springer Spaniels navigating a new murmur or valve diagnosis, and wanting to understand what the years ahead actually look like, are the primary audience for this topic.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
We research and check what we publish, but we do not warrant that any figure, date, price, or statement is accurate, complete, or current, and we accept no liability for any loss, cost, injury, or other harm arising from the use of this site. Use it as one reference among several. You remain responsible for your own decisions and for your dog's care - confirm anything that matters with a licensed veterinarian or another qualified professional before you act on it. Full disclaimer.
Myxomatous mitral valve disease is a gradual degeneration of the heart's mitral valve most associated with small toy breeds, and it is not documented as a defining condition for Welsh Springer Spaniels. It remains a common general aging-heart condition, and given this breed's twelve to fifteen year lifespan, understanding its staged progression helps owners of senior dogs know what to realistically expect.
MMVD is not documented as a leading condition specifically for this breed, but it is one of the most common cardiac conditions across dogs generally in their senior years, making it a reasonable, if not breed-defining, consideration for an aging Welsh Springer Spaniel.
Welsh Springer Spaniels are not documented as a breed with elevated genetic risk for MMVD the way small toy breeds are, so its occurrence here is best understood as part of general age-related valve wear rather than an inherited breed-specific vulnerability, made more relevant simply because this breed's twelve to fifteen year lifespan gives more years for such wear to accumulate.
Consistent senior wellness exams, weight management, and overall cardiovascular health throughout life all influence how early a developing valve issue is caught, though the underlying degeneration itself is primarily an aging process rather than an environmentally driven one.
Talk to your vet if you notice a persistent cough, reduced exercise tolerance, faster breathing at rest, or fainting, especially in a senior dog, so staging can be reassessed. Sudden severe breathing difficulty, blue-tinged gums, or collapse are signs of acute heart failure and require emergency veterinary care immediately.
See all Welsh Springer Spaniel health problems, which breeds are prone to myxomatous mitral valve disease mmvd, or the full Welsh Springer Spaniel breed guide for temperament, exercise needs and ownership costs.
Progression from an early, symptom-free stage to one requiring active treatment often takes one to several years, and even after treatment begins, many dogs maintain good quality of life for a meaningful additional stretch of time.
Success looks like catching valve changes early through consistent senior screening, tracking progression through staged monitoring, and maintaining comfortable quality of life for as long as the disease's natural course allows.
MMVD is typically described using a staging system that reflects how far the disease has progressed rather than treating diagnosis as a single moment. Stage B1 describes a dog with a detectable murmur and mild valve changes on echocardiogram, but no heart enlargement and no symptoms at all; many dogs live for years at this stage without any treatment needed beyond monitoring.
Stage B2 describes meaningful heart enlargement from the valve leak, still without obvious symptoms like coughing or exercise intolerance, and this is typically when vets begin discussing preventive medication aimed at slowing further progression. Stage C marks the onset of actual congestive heart failure symptoms, fluid backing up into the lungs, a persistent cough, and reduced exercise tolerance, requiring more active medical management. Stage D describes advanced disease that has become resistant to standard treatment, requiring more intensive intervention.
For a dog with a twelve to fifteen year lifespan, this staging system matters because a valve degeneration that begins in the senior years might take several more years to progress meaningfully, meaning many Welsh Springer Spaniels diagnosed with early-stage MMVD go on to live comfortable, largely normal lives for a substantial stretch of time afterward, with the diagnosis becoming a routine monitoring item rather than an immediate crisis.
Because this disease typically progresses slowly, most of the practical work is about consistent monitoring and knowing what changes actually warrant a call to the vet.
If you think your Welsh has myxomatous mitral valve disease (mmvd), the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers hip dysplasia, ear infections, epilepsy.
What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.
Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for myxomatous mitral valve disease (mmvd) it is often what separates a clear pattern from a guess.
At her eleven-year-old Welsh Springer Ellie's routine senior exam, Patricia's vet detected a new, soft murmur that hadn't been there the year before. An echocardiogram confirmed early-stage MMVD, still at stage B1 with no heart enlargement and no symptoms at all. Rather than starting medication immediately, Patricia's vet recommended rechecking every six months to watch for progression to stage B2, along with continuing Ellie's normal, moderate exercise routine. Patricia also learned to count Ellie's resting breathing rate as a simple at-home check between visits. Two years later, at age thirteen, Ellie's disease progressed to stage B2, and her vet started preventive medication at that point, exactly the juncture the staging system is designed to catch.
Key takeaway: A valve diagnosis late in a long lifespan is often the start of years of manageable monitoring rather than a sudden crisis, which is why understanding the staging system matters more than the diagnosis word itself.
No. MMVD is best known in small toy breeds like the Cavalier King Charles Spaniel and is not documented as a hallmark condition for this breed specifically, but it remains a common aging-heart condition that can occur in any dog living into its senior years.
MMVD is staged from B1, a mild murmur with no heart enlargement, through B2, meaningful heart enlargement without symptoms, to C and D, where actual congestive heart failure symptoms appear and require active medical management.
Many dogs live comfortably for years at the earliest stages with monitoring alone, and even once treatment begins, dogs often maintain good quality of life for a meaningful additional stretch of time.
A persistent cough, reduced exercise tolerance, faster breathing at rest, or fainting are signs of disease progression worth reporting to your vet, since they can indicate a shift toward more advanced stages.
Preventive medication is often started once meaningful heart enlargement is detected at stage B2, even before symptoms appear, since starting earlier can help slow further progression.
A vet can teach you to count breaths per minute while your dog is calmly resting or sleeping; a rising resting respiratory rate over time can be an early, free indicator of fluid buildup worth reporting.
No, MMVD is best known in small toy breeds and is not documented as a hallmark condition for Welsh Springer Spaniels specifically, though it can still occur as a general aging-heart condition.
MMVD progresses through stages from a mild murmur with no symptoms to eventual congestive heart failure symptoms, and progression can take years, especially when caught early.
A persistent cough, reduced exercise tolerance, or faster resting breathing rate suggest progression and are worth reporting to your vet promptly.
Yes, learning to count your dog's resting breaths per minute is a simple, free way to catch early signs of fluid buildup between scheduled vet visits.
Echocardiogram rechecks and, once started, ongoing medication represent real recurring costs, so it is worth confirming whether your pet insurance covers cardiac management before a diagnosis occurs.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.
